Showing results (101-110 of 111) with videos related to
Sort By:
Pageof 12
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|July 1, 1997
Percutaneous penetration of N-nitroso-N-methyldodecylamine through human skin in vitro: application from cosmetic vehiclesK A Walters, K R Brain, W E Dressler, et al.The Journal of Clinical Endocrinology and Metabolism|September 13, 2003
Adenovirus-mediated expression of dominant negative fibroblast growth factor (FGF) receptor 1 in thyroid cells blocks FGF effects and reduces goitrogenesis in miceEmma L Davies, James D Ramsden, Helen Cocks, et al.The Journal of Clinical Endocrinology and Metabolism|May 3, 2003
Pituitary tumor transforming gene and fibroblast growth factor-2 expression: potential prognostic indicators in differentiated thyroid cancerK Boelaert, C J McCabe, L A Tannahill, et al.Carcinogenesis|October 31, 2006
Securin induces genetic instability in colorectal cancer by inhibiting double-stranded DNA repair activityD S Kim, J A Franklyn, V E Smith, et al.The Journal of Clinical Endocrinology and Metabolism|May 17, 2013
Manipulation of PBF/PTTG1IP phosphorylation status; a potential new therapeutic strategy for improving radioiodine uptake in thyroid and other tumorsV E Smith, N Sharma, R J Watkins, et al.Journal of Cell Science|August 27, 2009
A novel mechanism of sodium iodide symporter repression in differentiated thyroid cancerVicki E Smith, Martin L Read, Andrew S Turnell, et al.Oncogene|May 16, 2017
Elevated PTTG and PBF predicts poor patient outcome and modulates DNA damage response genes in thyroid cancerM L Read, J C Fong, B Modasia, et al.Cancer Research|August 17, 2011
Proto-oncogene PBF/PTTG1IP regulates thyroid cell growth and represses radioiodide treatmentMartin L Read, Greg D Lewy, Jim C W Fong, et al.Endocrinology|February 11, 2014
The PTTG1-binding factor (PBF/PTTG1IP) regulates p53 activity in thyroid cellsMartin L Read, Robert I Seed, Jim C W Fong, et al.Human Molecular Genetics|March 6, 2016
Germline ESR2 mutation predisposes to medullary thyroid carcinoma and causes up-regulation of RET expressionJoel Smith, Martin L Read, Jon Hoffman, et al.Pageof 12